THE EFFECTS OF LOW DOSE HYDROXYCHLOROQUINE AND AZITHROMYCIN COMBINATION THERAPY ON COVID-19 PROGNOSIS
Naderali E. K.*, Naderali M. M. and Wong C. F.
ABSTRACT
Background and Objective: The global pandemic of COVID-19 has challenged medical and scientific communities to produce effective therapy options for this new highly contagious virus. At present there are no effective treatment thus utilizing existing medication to counter COVID-19 is vital. This report outlines the safety, tolerability and effectiveness of combination of hydroxychloroquine and azithromycin in COVID-19 prognosis. Methods: From 18th March to 30th September 2020, fifteen COVID-19 patients from different parts of Iran were treated at their home following the diagnosis of COVID-19 infection. Diagnosis was confirmed by chest CT scan examination between 18th March 2020 till 10th July 2020 and by PCR testing from 11th July 2020 till 30th September 2020. Results: All 15 patients fully recovered from their symptoms following administration a of low dose hydroxychloroquine (200 mg mane for 10 days) and azithromycin (500 mg nocte for 7 days). There were no adverse events due to therapy and the combination therapy was well tolerated. Conclusion: At the time that there are no bespoke therapy options available for COVID-19, high mortality rate could be reduced by low dose hydroxychloroquine and azithromycin combination therapy.
[Full Text Article] [Download Certificate]